List of Devices Companies in Pennsylvania - 29

Actuated Medical has quickly emerged as a leader in the design and development of medical devices and components. Using proprietary actuation technologies, our innovations address a wide variety of medical challenges ranging from clearing occlusions to easing tissue penetration to enabling MRI assisted procedures. From start to finish, our team designs, develops and manufactures under an ISO-certified quality control system. In addition, we continually seek feedback from domain experts to ensure our products not only solve real problems but also are readily accepted by clinicians. With a proven track record of receiving federal grants to support research and development, the company has built a successful business model that takes medical devices from conception to regulatory approval to market.

AIROS™ Medical, Inc. is a medical technology manufacturer, designer, and specification developer specializing in compression therapy. Our team of engineers, quality and regulatory experts, and clinical partners create medical devices that improve quality of life for patients battling lymphatic and venous disorders, including the AIROS 6 and AIROS 8 Sequential Compression Device systems.

Animal Biotech Industries, Inc. is a private corporation that was established in 1990 to support the biomedical research community by supplying them with high quality post mortem tissues, organs and glands. To this end, ABI was conceived and is currently operated by scientific professionals who have dedicated themselves to producing superior animals and tissues as well as superior service.

Biocoat Incorporated develops and licenses biomaterial coatings for medical devices that are custom engineered to meet client design parameters. Its specialty is supplying lubricious hydrophilic coatings for medical devices. Our full-service coating solution includes industry-leading coating performance, high-touch customer service, and dip coating equipment that is specifically designed to maximize the coating process. HYDAK® Hydrophilic Coating Advantages * Exceptionally hydrophilic * Lubricious when wet, preventing trauma and tissue abrasion * Abrasion resistant * Very thin, flexible coatings can be applied * Biocompatible * Non-thrombogenic * Prevents adhesion of platelets, proteins, microorganisms * Carrier for bioactive substances to make o anti-bacterial surfaces o anti-thrombogenic surfaces

Cerora (www.cerora.com) is devoted to alleviating suffering and empowering people by transforming antiquated opinion-based methods into enlightened biosensor-based neurodiagnostics. The company intends to make a major positive impact in brain health assessment globally with an initial focus on concussion. The Company is leading the way in the development and testing of mobile software and hardware technologies required to provide critical, objective, biomarker-based brain function diagnostic information. Located in the high-tech nexus at Ben Franklin Technology Partners of Northeastern Pennsylvania's Tech Ventures on Lehigh University's Mountaintop Campus in Bethlehem, Pennsylvania, Cerora has assembled a team of experienced medical scientists and management professionals.

DSG, Inc. is a leading global eClinical provider with a fully unified suite of innovative technology solutions and data management services for the global clinical research community. DSG's eClinical software platform provides competitive advantage that is cost-effective with on-time project delivery. DSG solutions have been used in thousands of clinical trials around the globe with our award-winning eCaseLink™ platform and eCaseLink Designer for enterprise licensing. Founded in 1992, the company is proud to be recognized as the first provider of a fully integrated EDC and IRT Randomization and Trial Supply Management system with the SCDM Data Driven Innovation Award. For more information, please visit www.dsg-us.com

Escalon, operates in the healthcare market, develop, manufacture, marketing, and distribution of medical devices for use in ophthalmology.

In 2005, Esco Technologies was incorporated in Philadelphia to seek new technologies. In addition, Esco Biotech Inc was established in Houston to sell Esco Lab products, which then merged into a new facility in Hatboro, PA two years later. In 2012, the Pharma and Medical divisions were established, with Pharma having a factory in Feasterville, PA. With sales growth accelerating, the company relocated into a much larger premise in Horsham in 2015 — a move that enabled an extensive expansion of our sales network throughout the US and Canada, making Esco Technologies a one-stop shop and key player for Life Sciences, Medical and Pharma in North America.

H.B. Fuller | Adhezion Biomedical, LLC is a medical device company focused on the development and commercialization of highly differentiated cyanoacrylate based surgical, wound management and infection prevention technologies. Founded in 2001, the company is based in Wyomissing, Pennsylvania. The vision of the Adhezion team is to redefine the way cyanoacrylate based surgical adhesives and sealants are used in medicine. Our mission is to provide technologies that achieve optimal patient outcomes. Adhezion currently is developing and commercializing cyanoacrylate‐based adhesives and sealants for use in both professional and consumer healthcare settings.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain’s ability to compensate and promotes neuroplasticity, aiming to improve the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS). PoNS™, short for Portable Neuromodulation Stimulator, is an innovative medical device. It is inclusive of a controller and mouthpiece, that delivers mild stimulation to the surface of the tongue. This stimulation triggers a flow of neural impulses to the brain structures that control balance and gait. PoNS is meant to be used in conjunction with supervised therapeutic activity, referred to as, PoNS Therapy™. Use of the device while engaging in movement and coordination tasks promotes neuromodulation, activating brain pathways to help improve balance and gait. PoNS is authorized in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. PoNS is authorized in Canada for three indications: (i) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) and is to be used in conjunction with physical therapy; and (ii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke, to be used in conjunction with physical therapy. PoNS is authorized in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait.

InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. InfraScan Inc.'s patented NIR technology for diagnosing brain hematomas enables neurosurgeons to effectively, conveniently, and accurately detect intracranial bleeding in patients with Head Trauma.

The OcuCheck is a point-of-care device that uses a specialized electrical chemical sensor with proprietary coatings to measure specific biomarkers in the tear film Currently, the OcuCheck is the only device that can simultaneously measure MMP-9 and tear film osmolarity in one device. It is also one of the most accurate devices for quantitative measurement of MMP-9.

To make bold and positive change in the biomedical and technology markets. An innovation hub, we relentlessly pursue ideas and inventions that result in superior products, processes, and design. This relentless pursuit drives us every day to bring ideas to market that improve lives and give back to the communities in which we operate.

LifeLens was founded in 2014 by Dr. Robert Schwartz, Landy Toth, David Robins, and Dr. Robert Van Tassel. Its mission is to create simple, commercially viable technologies for high fidelity physiologic monitoring.

TandemLife is a medical device company that develops a circulatory system to provide support for patients during cardiopulmonary bypass procedures.

Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities where an unmet need exists for improved patient safety and efficacy. Medicus is opportunisticly exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.

NeuroStar is a medical devices company that offers therapeutic solutions in the field of neuroscience and mental health.

OraSure Technologies developd, manufactured and distributed of point-of-care diagnostic tests, molecular collection devices. These include rapid tests for the detection of antibodies to HIV and Hepatitis C (HCV) on the OraQuick® platform; sample self-collection and stabilization products for molecular applications; and oral fluid laboratory tests for detecting various drugs of abuse. Orasure's wholly-owned subsidiaries include DNA Genotek, CoreBiome, and Novosanis.COVID-19: BARDA funded the development of a rapid coronavirus test that can be self-administered at home.

Orchestra BioMed biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine.

The Lubrizol Corporation, a Berkshire Hathaway company, is a specialty chemical company whose science delivers sustainable solutions to advance mobility, improve wellbeing and enhance modern life. Founded in 1928, Lubrizol owns and operates more than 100 manufacturing facilities, sales and technical offices around the world and has more than 8,000 employees. For more information, visit www.Lubrizol.com.

Polysciences introduces Kyfora Bio, our bioprocessing brand, supporting development of cell and gene therapy (CGT) breakthroughs from bench to clinic. Backed by 60+ years of specialty chemical development, manufacturing, and application expertise, Kyfora provides research grade through cGMP transfection reagents and excipients for viral vectors, mRNA vaccines, and other drug delivery applications. Our cost-effective and scalable cGMP processes empower advanced therapies to improve patient lives.

Rx-360 is a pharmaceutical industry consortium that aims to improve the quality and security of supply chains for proprietary and generic pharmaceutical companies and suppliers.

STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing cutting-edge solutions for the in-office treatment of various dermatologic conditions. Backed by decades of experience, STRATA offers an ever-growing portfolio of best-in-class skin science technology, through an innovative partnership approach that advances treatment options for life-altering skin conditions including psoriasis, vitiligo and atopic dermatitis.

The InfantEar Molding System can easily be performed in your medical office and requires only 2-3 weeks of molding time to transform a deformed ear into a healthy and more natural-looking ear, if treated in the first two weeks of life. Contact TalexMedical, LLC

Thrombolex is engaged in the design, development, and distribution of innovative endovascular catheters used in interventional procedures, particularly in pharmaco-mechanical catheter-directed thrombolysis (PM-CDT) in patients who suffer from arterial and venous thromboembolic (A&VTE) conditions. The Company is currently marketing seven (7) different FDA-cleared devices that are all based on the BASHIR™ Endovascular Catheter platform technology.

A privately held company, since 1996 ValSource has remained the better solution for the regulated pharmaceutical industry worldwide. The ValSource family of companies delivers Line of Sight approach consulting services, resources and solutions for the biological, medical device, and pharmaceutical industries. The Line of Sight approach begins with the end objective in mind. It links critical phases of process development, validation, and manufacturing, doing what is necessary, but only what is necessary, to ensure effective, compliant processes. By process mapping from the desired outcome to the process start, we logically develop better objective-focused solutions. ValSource’s 300+ strong talent force is comprised of full-time employees. We are mechanical engineers, electrical engineers, computer engineers, computer scientists, chemical engineers, chemists, statisticians, life scientists and microbiologists. As industry leaders, we serve in positions of consequence, using critical thinking to help shape the conversation and drive progress for our industry and the clients we serve.

The "SUTURE-TIGHT" tm catheter secures endovascular aortic repair grafts to the aorta at the time of initial implant or during repair procedures. (EVAR/TEVAR/TAVR) The "SUTURE-TIGHT" tm device is not commercially available.

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.twitter.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

At Vitara, we are working to offer preterm newborns and their families a lifetime of possibilities. We seek to transform neonatal care by protecting more preterm infants and improving their quality of life.